Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

M

McGill University

Other

0

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

0

Indications↗

Distinct diseases across all programs

31

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Operation Calm: VR Nature-Based Mindfulness to Reduce Pediatric Surgical Anxiety

Dietary Protein Requirements in Adults With Facioscapulohumeral Muscular Dystrophy

Protecting the Brain From Post-Stroke Cognitive Impairment and Dementia With Multimodal Exercise Training: A Bayesian Adaptive Trial (PROTECT)

Earlier

Sep 1, 2025TrialEffects of Omeprazole Ingestion on Postprandial Amino Acid Concentrations in Response to a Mixed Meal

Dec 5, 2024TrialContinuous Ketone Monitoring in People With Type 1 Diabetes Using SGLT2 Inhibitors

Nov 1, 2022TrialThe Covid-19 Outpatient Symptom Montelukast Oximetry Trial

Nov 12, 2021TrialCo-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Mar 26, 2021TrialEnoxacin for Amyotrophic Lateral Sclerosis (ALS)

4 more events

Nov 2, 2020TrialLow Dose Empagliflozin in Adults With Type 1 Diabetes on Closed Loop Insulin System

Feb 14, 2020TrialAlleviating Carbohydrate Counting for Patients With Type 1 Diabetes Using a Novel Insulin-plus-pramlintide Artificial Pancreas

Feb 8, 2019TrialInsulin-plus-pramlintide Closed-loop Strategy to Regulate Glucose Levels Without Carbohydrate Counting

Mar 1, 2017TrialCAN BREATHE in COPD Trial

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)